Skip to main content
    G

    GlucoTrack Inc (GCTK)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $0.22
    -0.02 (-7.38%)

    Market Cap: $2.43M

    Last updated: Nov 13, 2026 at 4:00 PM ET

    GlucoTrack Inc (GCTK) Financials: Revenue, Profit and Cash Flow

    Updated Aug 14, 2026. Financial statements from company filings, amounts in US dollars.

    GlucoTrack reported revenue of $0 for the fiscal year ended Dec 31, 2025. That year, net income was -$19.39M, operating cash flow was -$15.24M and free cash flow was -$15.34M. The quarter ended Jun 30, 2026 had revenue of $0 and net income of -$3.81M.

    Revenue and Margins

    The company reported no revenue in the fiscal year ended Dec 2025, with an operating loss of $16.09M.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$0N/AN/AN/AN/A
    Dec 2024$0N/AN/AN/AN/A
    Dec 2023$0N/AN/AN/AN/A
    Dec 2022$0N/AN/AN/AN/A
    Dec 2021$0N/AN/AN/AN/A
    Dec 2020$0-100.0%N/AN/AN/A
    Dec 2019$208.00K+378.3%100.0%-1685.6%-1690.4%
    Dec 2018$43.49K-92.6%100.0%-15035.4%-15442.0%
    Dec 2017$589.46K-3.6%100.0%-1794.2%-1752.2%
    Dec 2016$611.69KN/A100.0%-924.6%-884.4%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Jun 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$0$0$0$0$0$0$208.00K$43.49K$589.46K$611.69K
    Gross profit$0$0$0$0$0$0$208.00K$43.49K$589.46K$611.69K
    Research and development$9.81M$9.50M$4.70M$1.97M$1.81M$1.53M$1.61M$3.03M$3.21M$2.88M
    Operating income-$16.09M-$14.55M-$7.10M-$4.43M-$4.04M-$3.13M-$3.51M-$6.54M-$10.58M-$5.66M
    Net income-$19.39M-$22.60M-$7.10M-$4.43M-$4.07M-$2.70M-$3.52M-$6.72M-$10.33M-$5.41M
    EBITDAN/AN/A-$7.09M-$4.42MN/A-$2.75M-$3.46MN/A-$10.26M-$5.35M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Revenue$0$0$0$0$0$0$24.00K$0$0$0$42.00K$0
    Gross profit$0$0-$14.00K$0$0$0-$14.00K$0$0$0$21.00K$0
    Operating income-$3.40M-$4.20M-$3.49M-$4.31M-$4.80M-$3.50M-$3.85M-$3.25M-$4.49M-$2.95M-$2.42M-$2.22M
    Net income-$3.81M-$4.33M-$3.63M-$4.17M-$4.76M-$6.83M-$10.09M-$5.09M-$4.49M-$2.93M-$2.41M-$2.22M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded total debt of $3.41M by $3.97M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$7.84M$5.93M$4.91M$2.44M$6.26M$10.61M$1.10M$688.19K$1.67M$2.46M
    Current assets$7.67M$5.77M$4.87M$2.38M$6.11M$10.23M$718.00K$314.14K$1.23M$2.02M
    Cash and equivalents$7.38M$5.62M$4.49M$2.31M$6.06M$9.82M$419.00K$97.08K$53.78K$148.84K
    Total liabilities$5.01M$18.93M$1.71M$1.21M$1.11M$1.62M$2.51M$3.56M$4.82M$3.37M
    Short-term debt$3.18M$5.00K$0N/A$23.00K$84.00K$142.00KN/AN/AN/A
    Long-term debt$231.00K$203.00K$196.00K$195.00K$210.00K$197.00K$190.37K$168.22KN/AN/A
    Shareholder equity$2.83M-$13.00M$3.20M$1.23M$5.16M$8.98M-$1.41M-$2.87M-$16.57M-$10.95M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total assets$1.50M$4.36M$7.84M$8.29M$10.21M$9.61M$5.93M$826.00K$608.00K$2.11M$4.91M$7.20M
    Total liabilities$3.24M$5.21M$5.01M$5.54M$3.33M$2.35M$18.93M$4.85M$3.90M$1.73M$1.71M$1.64M
    Cash and equivalents$1.12M$3.93M$7.38M$7.87M$9.55M$9.10M$5.62M$346.00K$159.00K$1.50M$4.49M$6.89M
    Shareholder equity-$1.74M-$851.00K$2.83M$2.75M$6.88M$7.26M-$13.00M-$4.02M-$3.29M$376.00K$3.20M$5.56M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$15.24M-$12.49M-$6.56M-$3.73M-$3.77M-$3.50M-$3.90M-$4.89M-$5.90M-$5.31M
    Capital expenditures$96.00K$104.00K$0$1.00K$5.00K$53.00K$23.00K$5.37K$19.47K$76.45K
    Free cash flow-$15.34M-$12.59M-$6.56M-$3.73M-$3.77M-$3.55M-$3.92M-$4.90M-$5.91M-$5.39M
    Dividends paidN/AN/AN/AN/AN/AN/AN/A$0$5.73K$13.53K
    Share repurchases$166.00K$0N/AN/AN/AN/AN/AN/AN/AN/A
    Investing cash flow-$96.00K-$104.00K$0$1.00K-$1.00K-$53.00K-$23.00K-$5.37K-$19.47K-$76.45K
    Financing cash flow$17.04M$13.74M$8.73M$0$0$13.01M$4.20M$4.96M$5.75M$4.94M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Operating cash flow-$3.62M-$4.05M-$3.94M-$4.62M-$3.74M-$2.94M-$3.50M-$4.14M-$1.91M-$2.94M-$2.41M-$1.88M
    Capital expendituresN/A$0$20.00K$67.00K$0$9.00K$0$33.00K$12.00K$59.00K$0$0
    Free cash flowN/A-$4.05M-$3.96M-$4.69M-$3.74M-$2.95M-$3.50M-$4.17M-$1.92M-$3.00M-$2.41M-$1.88M
    Last 12 quarters

    Frequently Asked Questions About GCTK

    What is GlucoTrack's annual revenue?

    GlucoTrack reported revenue of $0 for the fiscal year ended Dec 31, 2025.

    Is GlucoTrack profitable?

    No. GlucoTrack reported net income of -$19.39M for the fiscal year ended Dec 31, 2025.

    How much free cash flow does GCTK generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$15.24M minus capital expenditures of $96.00K produced free cash flow of -$15.34M.

    How much debt does GlucoTrack have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $231.00K, short-term debt of $3.18M and cash and equivalents of $7.38M.